Avery Therapeutics, Inc.
PrivateLast Round
Seed
May 22, 2018
Total Funding Raised
$4.29M
Company Overview
Avery Therapeutics, Inc. is a biotechnology company developing immunomodulatory biologic and tissue-engineered therapeutics designed to treat diseases and injuries of human muscles.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avery Therapeutics, Inc. Comparables
Compare Avery Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Heartseed | 76% | |
| Bayer AG | 70% | |
| Jaan Biotherapeutics | 66% | |
Avery Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 22, 2018 | ||||
| Grant | Jan 1, 2018 | ||||
| Grant | Nov 3, 2016 | ||||
| Grant | Aug 22, 2016 |
Key People
Founding team and executive leadership
Avery Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Cox Communications | Grant |
| Arizona Geological Survey | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2025
Monthly visitors increased 31% MoM.
- May 3, 2025
Monthly visitors grew 88% MoM.
Avery Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avery Therapeutics, Inc.'s valuation, stock price, and market status.